Szmit , S., Jędrzejczak , W. W., & Opolski , G. (2013). Consensus statement on indications for the use of non-pegylated liposomal doxorubicin in patients with lymphomas and concomitant cardiovascular diseases. OncoReview, 3(3(11), 213-215. Retrieved from https://journalsmededu.pl/index.php/OncoReview/article/view/345